Profil
Dr. Shinichiro Fuse is a Partner and Managing Director at TPG Capital LLC.
He is on the Board of Directors at Santa Ana Bio, Inc. Dr. Fuse was previously employed as a Member-Supervisory Board by iOmx Therapeutics AG, a Managing Director by MPM BioImpact LLC, an Associate by PureTech Ventures LLC, and a Consultant by Clarion Healthcare Consulting.
He also served on the board at Orna Therapeutics, Inc. and Triplet Therapeutics, Inc. He received his undergraduate degree from Keio University, a graduate degree from the University of Tokyo and a doctorate degree from Dartmouth College.
Postes actifs de Shinichiro Fuse
| Sociétés | Poste | Début |
|---|---|---|
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Directeur/Membre du Conseil | - |
TPG Capital LLC
TPG Capital LLC Investment ManagersFinance TPG Capital seeks investment opportunities in companies located across the globe. The firm focuses on companies operating in fields of wide range of sectors. It provides equity financing for buyout transactions. | Private Equity Investor | - |
Anciens postes connus de Shinichiro Fuse
| Sociétés | Poste | Fin |
|---|---|---|
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Membre du Comité d'Investissement | 01/10/2021 |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Directeur Général | - |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Analyste en capital-investissement | 02/07/2012 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Directeur/Membre du Conseil | - |
Triplet Therapeutics, Inc.
Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Directeur/Membre du Conseil | - |
Formation de Shinichiro Fuse
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
TPG Capital LLC
TPG Capital LLC Investment ManagersFinance TPG Capital seeks investment opportunities in companies located across the globe. The firm focuses on companies operating in fields of wide range of sectors. It provides equity financing for buyout transactions. | Finance |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keio University
Keio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarion Healthcare Consulting | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
Triplet Therapeutics, Inc.
Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Health Services |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Health Technology |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Health Technology |
















